Inventor · disambiguated record
Hasane Ratni
Also filed as: RATNI HASANE
89 granted patents·38 pending applications·350 citations·filing 2005–2024
99Inventor score
Files withHOFFMANN LA ROCHE76BISSANTZ CATERINA12KNUST HENNER10PTC THERAPEUTICS INC9SKYHAWK THERAPEUTICS INC6
Top patents by PatentIndex Score
127 records- 0197US9969754B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2016·Granted May 15, 2018·25 cites·38 claims
- 0295US10562903B2Bridged piperidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Feb 18, 2020·12 cites·24 claims
- 0395US9879007B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·18 cites·4 claims
- 0495US9371336B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Jun 21, 2016·36 cites·5 claims
- 0594US9617268B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2012·Granted Apr 11, 2017·32 cites·5 claims
- 0694US9586955B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Mar 7, 2017·22 cites·21 claims
- 0793US11827646B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2020·Granted Nov 28, 2023·2 cites·24 claims
- 0893US7781436B2Indol-3-y-carbonyl-piperidin and piperazin-derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Aug 24, 2010·21 cites·8 claims
- 0993US7351706B2Indol-3-yl-carbonyl-spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Apr 1, 2008·26 cites·21 claims
- 1091US10882868B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2018·Granted Jan 5, 2021·4 cites·13 claims
- 1189US7332501B2Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonistsHOFFMANN LA ROCHE·Filed 2006·Granted Feb 19, 2008·13 cites·50 claims
- 1288US7799923B2IndolesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 21, 2010·10 cites·21 claims
- 1387US8022099B2N-benzyl pyrrolidine derivativesHOFFMANN LA ROCHE·Filed 2009·Granted Sep 20, 2011·11 cites·53 claims
- 1487US7173048B2Indolyl derivatives as liver-X-receptor (LXR) modulatorsHOFFMANN LA ROCHE·Filed 2005·Granted Feb 6, 2007·9 cites·25 claims
- 1586US7812021B2Pyrrolidine aryl-ether as NK3 receptor antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Oct 12, 2010·10 cites·16 claims
- 1686US7253282B2Hexafluoroisopropanol substituted cyclohexane derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Aug 7, 2007·8 cites·22 claims
- 1784US8063075B2Pyrrolidine ether derivatives as NK3 receptor antagonistsJABLONSKI PHILIPPE·Filed 2009·Granted Nov 22, 2011·9 cites·11 claims
- 1884US7498339B2Spiropiperidine glycinamide derivativesHOFFMANN LA ROCHE·Filed 2008·Granted Mar 3, 2009·8 cites·19 claims
- 1984US2024067646A1Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2083US10941147B2Bicyclic heteroaryl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Mar 9, 2021·5 cites·12 claims
- 2183US7803815B2Indol-3-yl-corbonyl-piperidin-benzoimidazol derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Sep 28, 2010·5 cites·8 claims
- 2283US2024076302A1Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2382US10730881B2Fused pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2019·Granted Aug 4, 2020·2 cites·13 claims
- 2482US10208067B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2017·Granted Feb 19, 2019·5 cites·33 claims
- 2581US8022213B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 20, 2011·4 cites·23 claims
- 2681US7629353B2Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Dec 8, 2009·4 cites·25 claims
- 2780US11370802B2Triazolo-azepine derivativesHOFFMANN LA ROCHE·Filed 2019·Granted Jun 28, 2022·2 cites·11 claims
- 2880US9975900B2Substituted imidazo[1,2-α]pyrazines for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2016·Granted May 22, 2018·2 cites·20 claims
- 2980US8012998B2Pyrrolidine aryl-ether as NK-3 receptor antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Sep 6, 2011·4 cites·8 claims
- 3080US7893062B2Pyrrolidine derivatives as dual NK1/NK3 receptor antagonistsHOFFMANN LA ROCHE·Filed 2008·Granted Feb 22, 2011·4 cites·15 claims
- 3180US7470684B2Spiropiperidine derivatives as NK3 antagonistsHOFFMANN LA ROCHE·Filed 2007·Granted Dec 30, 2008·6 cites·31 claims
- 3279US7608721B2Hexafluoroisopropanol derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Oct 27, 2009·2 cites·17 claims
- 3378US10501482B2Compounds for treating spinal muscular atrophyHOFFMANN LA ROCHE·Filed 2018·Granted Dec 10, 2019·2 cites·31 claims
- 3478US8618303B2Pyrrolidine derivativesKNUST HENNER·Filed 2012·Granted Dec 31, 2013·4 cites·17 claims
- 3578US7259178B2Hexafluoroisopropanol derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Aug 21, 2007·2 cites·22 claims
- 3677US7495008B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Feb 24, 2009·2 cites·25 claims
- 3777US7432259B2Spiro-piperidine derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Oct 7, 2008·2 cites·24 claims
- 3877US2025101034A1Compositions useful for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3977US2025340564A1Compositions useful for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4077US2025129090A1Compositions useful for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4177US2025127789A1Compositions useful for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4276US11440915B2Triazolo-azepine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Sep 13, 2022·1 cites·13 claims
- 4376US2025340570A1Compositions useful for modulating splicingSKYHAWK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4475US2025326758A1Ricyclic heteroaryl derivativesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4574US10899766B2Bridged piperidine derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jan 26, 2021·1 cites·13 claims
- 4674US9023852B21, 2, 4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseasesGRIFFIOEN GERARD·Filed 2012·Granted May 5, 2015·3 cites·22 claims
- 4774US8404679B2Pyrrolidine derivatives as NK2 receptor antagonistsBISSANTZ CATERINA·Filed 2012·Granted Mar 26, 2013·2 cites·10 claims
- 4873US11319314B2PhenoxytriazolesHOFFMANN LA ROCHE·Filed 2017·Granted May 3, 2022·1 cites·19 claims
- 4973US7485652B2Indolyl derivatives as liver-X-receptor (LXR) modulatorsHOFFMANN LA ROCHE·Filed 2006·Granted Feb 3, 2009·1 cites·2 claims
- 5072US10604517B2Bridged piperidine derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Mar 31, 2020·1 cites·13 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hasane Ratni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →